[Skip to Content]
[Skip to Content Landing]
Views 450
Citations 0
Invited Commentary
October 14, 2020

Oncologic Outcomes After Neoadjuvant Chemotherapy and Postmastectomy Breast Reconstruction

Author Affiliations
  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina
  • 2Duke Cancer Institute, Duke University School of Medicine and Duke University Health System, Durham, North Carolina
JAMA Surg. Published online October 14, 2020. doi:10.1001/jamasurg.2020.4138

For women with breast cancer, rates of locoregional recurrence after skin- and nipple-sparing mastectomy are low (approximately 5%) and often exceeded by those for distant metastases.1,2 As a result, these contemporary mastectomy techniques in conjunction with breast reconstruction have become widely adopted owing to improved patient-reported outcomes related to cosmesis and quality of life.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words